Literature DB >> 20737999

Short introduction and history.

Robert B Raffa1.   

Abstract

If one does a MEDLINE search using as keywords chemo fog or chemo brain or their hyphenated equivalents, fewer than 30 'hits' appear. The oldest dates back to 2003. This small number of hits in some way captures one aspect of the current state of the phenomenon (or phenomena). In contrast, if one does the search using 'cognitive x cancer x chemotherapy', hundreds more hits appear. This in some way captures another aspect of the phenomenon.It is both little-known and well-known. To go a step further, some data suggest that it is one of the most common adverse effects of chemotherapy, other data suggest that it does not exist. Even its name (or lack thereof) is still unsettled. Yet, patients consistently report it. This chapter introduces the reader to the fascinating and complex challenges-to patients, healthcare providers, basic scientists, employers, insurers and others-inherent in this topic and the current state of knowledge about it.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20737999     DOI: 10.1007/978-1-4419-6306-2_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  1 in total

Review 1.  Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.

Authors:  Rex M Philpot
Journal:  Neurochem Res       Date:  2015-02-05       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.